City

Changsha (1)

Condition

Brain Metastases (1)

Capecitabine (1)

Metastatic HER2 Negative Breast Carcinoma (1)

UDT1 (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

Hunan Cancer Hospital (1)

Collaborator

Intervention

utd1 combined with capecitabine (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

udt1

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Metastatic HER2 Negative Breast Carcinoma, Brain Metastases, Capecitabine Trial in Changsha (UTD1 combined with capecitabine)

Recruiting

Metastatic HER2 Negative Breast Carcinoma
+3 more

UTD1 combined with capecitabine

Changsha, China

Quchang Ouyang

Sep 9, 2022